Risperidone Long-Acting Injectable Monotherapy in the Maintenance Treatment of Bipolar I Disorder

A New Depression Scale Designed to be Sensitive to Change

1979 • 12,729 citations

ECDEU Assessment Manual for Psychopharmacology

1976 • 8,729 citations

A Rating Scale for Mania: Reliability, Validity and Sensitivity

1978 • 8,000 citations

Bipolar Disorder

2011 • 3,572 citations

A Multiple Testing Procedure for Clinical Trials

1979 • 3,139 citations

Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression

2007 • 1,286 citations

The Health and Productivity Cost Burden of the “Top 10” Physical and Mental Health Conditions Affecting Six Large U.S. Employers in 1999

2003 • 695 citations

Long-Term Lithium Therapy for Bipolar Disorder: Systematic Review and Meta-Analysis of Randomized Controlled Trials

2004 • 624 citations

Long-Acting Injectable Risperidone: Efficacy and Safety of the First Long-Acting Atypical Antipsychotic

2003 • 474 citations

Social and economic burden of mood disorders

2003 • 420 citations

Randomized, Placebo-Controlled Trial of Olanzapine as Maintenance Therapy in Patients With Bipolar I Disorder Responding to Acute Treatment With Olanzapine

2006 • 313 citations

Treatment of Schizophrenia With Long-Acting Injectable Risperidone

2003 • 291 citations

Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena

2007 • 286 citations

Aripiprazole Monotherapy for Maintenance Therapy in Bipolar I Disorder

2007 • 241 citations

Treatment adherence with antipsychotic medications in bipolar disorder

2006 • 232 citations

Group sequential designs using a family of type I error probability spending functions

1990 • 220 citations

Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets

2004 • 196 citations

Enhancement of Treatment Adherence Among Patients With Bipolar Disorder

2004 • 161 citations

A randomized, double‐blind, placebo‐controlled study of maintenance treatment with adjunctive risperidone long‐acting therapy in patients with bipolar I disorder who relapse frequently

2009 • 157 citations

Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: Results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR)

2009 • 145 citations

Risks versus benefits of different types of long-acting injectable antipsychotics.

2006 • 107 citations

Mood state at study entry as predictor of the polarity of relapse in bipolar disorder

2004 • 101 citations

Comparison of the Prophylactic Action of Flupenthixol with Placebo in Lithium Treated Manic-Depressive Patients

1986 • 100 citations

Atypical antipsychotics in bipolar disorder: systematic review of randomised trials

2007 • 92 citations

A 1-Year Double-Blind Study of 2 Doses of Long-Acting Risperidone in Stable Patients With Schizophrenia or Schizoaffective Disorder

2006 • 82 citations

Long-Acting Formulations of Atypical Antipsychotics

2007 • 63 citations

Improving patient outcomes in schizophrenia: achieving remission

2006 • 63 citations

Atypical Antipsychotics for Bipolar Disorder

2005 • 48 citations

Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change

2008 • 44 citations

A 6‐month randomized open‐label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder

2007 • 42 citations

Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients

2008 • 35 citations

Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder

2007 • 31 citations

Continuation and prophylactic treatment of bipolar disorder.

1997 • 25 citations